BACKGROUND: In April 2009, the first cases of pandemic (H1N1)-2009 influenza [H1N1sw] virus were detected in France. Virological surveillance was undertaken in reference laboratories of the seven French Defence Zones. METHODOLOGY/PRINCIPAL FINDINGS: We report results of virological analyses performed in the Public Hospitals of Marseille during the first months of the outbreak. (i) Nasal swabs were tested using rapid influenza diagnostic test (RIDT) and two RT-PCR assays. Epidemiological characteristics of the 99 first suspected cases were analyzed, including detection of influenza virus and 18 other respiratory viruses. During three months, a total of 1,815 patients were tested (including 236 patients infected H1N1sw virus) and distribution...
International audienceThis short report based on clinical surveillance and laboratory data describes...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
In April 2009, the first cases of pandemic (H1N1)-2009 influenza [H1N1sw] virus were detected in Fra...
AbstractWe report here the results of a 7-month survey of the influenza A/H1N1 pandemic in the Virol...
We looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels of sera f...
In the spring of 2009, a new variant of influenza A/H1N1 virus that had never been isolated before, ...
In the spring of 2009, a new variant of influenza A/H1N1 virus that had never been isolated before, ...
AbstractWe looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels o...
In April 2009 a new influenza A(H1N1) virus of swine origin disseminated throughout the world, resul...
BACKGROUND: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observati...
<p>The purpose of this investigation was to determine the proportion of influenza-like illness...
AbstractIn contrast to the experience in other European countries, the onset of the A(H1N1)2009 infl...
Background: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observati...
International audienceIn the end of August 2009, an unusually elevated level of influenza-like illne...
International audienceThis short report based on clinical surveillance and laboratory data describes...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...
In April 2009, the first cases of pandemic (H1N1)-2009 influenza [H1N1sw] virus were detected in Fra...
AbstractWe report here the results of a 7-month survey of the influenza A/H1N1 pandemic in the Virol...
We looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels of sera f...
In the spring of 2009, a new variant of influenza A/H1N1 virus that had never been isolated before, ...
In the spring of 2009, a new variant of influenza A/H1N1 virus that had never been isolated before, ...
AbstractWe looked for evidence of antibodies to the 2009 influenza A/H1N1 pandemic virus in panels o...
In April 2009 a new influenza A(H1N1) virus of swine origin disseminated throughout the world, resul...
BACKGROUND: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observati...
<p>The purpose of this investigation was to determine the proportion of influenza-like illness...
AbstractIn contrast to the experience in other European countries, the onset of the A(H1N1)2009 infl...
Background: Influenza-like illness (ILI) may be caused by a variety of pathogens. Clinical observati...
International audienceIn the end of August 2009, an unusually elevated level of influenza-like illne...
International audienceThis short report based on clinical surveillance and laboratory data describes...
Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversion infection...
BACKGROUND: Knowledge of the age-specific prevalence of seroprotection and incidence of seroconversi...